Save time and get answers to complex questions with AI chat
Can i take anti histamine with statin?Pramlintide approval date?Drug patent watch trametinib?Norcuron generic name?Mobic injection patent oehringer ingelheim france?
See the DrugPatentWatch profile for Sublocade
What duration of effect can patients expect from Sublocade injections? The buprenorphine matrix-based injection, Sublocade, is designed for the treatment of moderate to severe opioid use disorder. According to the product's official guidelines [1], Sublocade contains a 30-day or 60-day dose of buprenorphine, which is gradually released into the body over a 4-week or 2-month period. Why was this duration chosen for Sublocade? Sublocade's extended release formulation was developed to mimic the natural fluctuation of buprenorphine levels in patients' bodies. By providing a consistent supply of the medication, healthcare providers can reduce the frequency of injections and associated administration costs. [2] How long does exclusivity expire for Sublocade? The U.S. patent for Sublocade's extended-release formulation by Indivior expires in 2029. [3] Why was the duration of Sublocade chosen in relation to opioid treatment? The 30-day or 60-day dosing schedule for Sublocade was selected to optimize the risk-benefit profile for opioid use disorder treatment. A single injection is administered every 4 weeks or 2 months, reducing the frequency of office visits for patients in need of ongoing buprenorphine therapy. [4] Sources: 1. Sublocade official website. (DrugPatentWatch.com drugpatentwatch.com 2. Indivior website [https://indivior.com/ 3. DrugPatentWatch.com. Indivior: SUBLOCADE. Retrieved June 11, 2026. www.drugpatentwatch.com 4. Sublocade official website.
Other Questions About Sublocade :